awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26738934-1854F179-B404-483B-899C-14F1107E3465
Q26738934-1854F179-B404-483B-899C-14F1107E3465
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738934-1854F179-B404-483B-899C-14F1107E3465
Ofatumumab plus chlorambucil as a first-line therapy in less fit patients with chronic lymphocytic leukemia: analysis of COMPLEMENT1 and other monoclonal antibodies association data
P2860
Q26738934-1854F179-B404-483B-899C-14F1107E3465
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738934-1854F179-B404-483B-899C-14F1107E3465
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1ab3c6166b367b6dbd49a3185cef64c6e3ad396f
P2860
Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study.